Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Lung Cancer News ••• Topics • Countries • U.S. States

Non-Small Cell Lung Cancer (NSCLC) News Monitoring

Get by Email • RSS

Published on 08:36 GMT

Bayer Sevabertinib gets USFDA Priority Review status for HER2-mutant non-small cell lung cancer

Berlin: Bayer has received Priority Review status from the US Food and Drug Administration (FDA) for the investigational compound sevabertinib (BAY 2927088) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) whose tumors …

Source: Medical Dialogues - Indeterminate
Published on May 28, 2025

U.S. FDA Accepts New Drug Application Under Priority Review for sevabertinib (BAY 2927088) in HER2-Mutant Non-Small Cell ...

Regulatory submission is based on positive results from the ongoing Phase I/II SOHO-01 trial in patients with advanced HER2-mutant non-small cell lung cancer (NSCLC). Investigational agent sevabertinib (BAY 2927088) is an oral, small molecule, tyrosine …

Source: The AI Journal - Pending
Published on 13:18 GMT

Merck, Daiichi Sankyo Pull NSCLC Filing for ADC, Citing Underwhelming Survival Findings

Merck and Daiichi Sankyo withdrew their regulatory application Thursday for the investigational antibody-drug conjugate patritumab deruxtecan, which the partners were proposing as a treatment for locally advanced or metastatic non-small cell lung cancer. …

Source: BioSpace - Pending
Published on 02:15 GMT

In Early NSCLC, Molecular Testing Rates Improve With EMR Nudge

Photo Credit: iStock.com/AndreyPopov An EMR-based prompt significantly boosted molecular testing rates and detection of actionable mutations in early-stage, non-squamous NSCLC post-surgery. An electronic medical record (EMR)-based intervention improved …

Source: Physician's Weekly - Neutral
Published on 02:15 GMT

High-Dose CCRT Plus Durvalumab May Be Safe, Efficacious in Stage III NSCLC

High-dose concurrent chemoradiotherapy (CCRT) followed by durvalumab (Imfinzi) showed a favorable safety profile and may provide clinical benefits vs lower-dose CCRT in patients with stage III non–small cell lung cancer (NSCLC) with a PD-L1 expression of …

Source: Cancer Network - New Jersey - Pending
Published on 01:22 GMT

FDA Grants Priority Review to Sevabertinib in HER2-Mutant NSCLC

The FDA has granted priority review to sevabertinib (BAY 2927088) for the treatment of advanced HER2-mutant non–small cell lung cancer (NSCLC). This designation is supported by the ongoing phase 1/2 SOHO-01 study (NCT05099172). Data from SOHO-01 showed …

Source: Targeted Oncology - Pending
Published on May 27, 2025

Elucidating the Role of FASN in Lung Cancer Stem Cells in Sensitive and Resistant EGFR-Mutated Non-Small Cell Lung ...

Introduction Lung cancer, as reported by the World Health Organization, is the most frequent cause of cancer-related fatalities globally for both men and women, representing 18.7% of all cancer-related deaths.1 Non-small cell lung cancer (NSCLC) is the …

Source: Dove Medical Press - Neutral
Published on May 28, 2025

Pharmacist Perspectives on ADC-Associated Toxicity in NSCLC Treatment

As antibody-drug conjugates (ADCs) become increasingly integrated into the treatment landscape for non–small cell lung cancer (NSCLC), understanding how to predict, prevent, and manage associated toxicities has become critical to optimizing patient care. …

Source: Pharmacy Times - Neutral
Published on 16:02 GMT

AstraZeneca Imfinzi recommended for approval in EU for adults with muscle-invasive bladder cancer

Cambridge: AstraZeneca has announced that Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) for the treatment of adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with gemcitabine and …

Source: Medical Dialogues - Indeterminate
Published on 10:25 GMT

AstraZeneca receives extended approval for lung cancer blockbuster in India

Bengaluru: AstraZeneca’s India arm has received approval from the Central Drugs Standard Control Organisation (CDSCO) for the import, sale, and distribution of osimertinib tablets for an expanded indication. The oral drug is now approved as monotherapy for …

Source: ETPharma.com - Pending
Published on 09:52 GMT

AstraZeneca gets CDSCO nod for lung cancer drug

AstraZeneca India Pharma receives government approval for import and distribution of lung cancer medication Osimertinib tablets. | Photo Credit: istock.com AstraZeneca India Pharma on Thursday said it has received approval from the government authority for …

Source: The Hindu Business Line - Neutral
Published on 12:40 GMT

Immutep's efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma

Immutep Limited, a late-stage immunotherapy company targeting cancer and autoimmune diseases, announced the investigator-initiated EFTISARC-NEO phase II trial evaluating eftilagimod alfa (efti) with radiotherapy plus Keytruda (pembrolizumab) in the …

Source: Pharmabiz.com - Neutral
Published on 15:15 GMT

Daiichi, Merck pull HER3-DXd filing at FDA after confirmatory trial misses survival endpoint

When Merck & Co. and Daiichi Sankyo last year received an FDA complete response letter for their HER3-directed antibody-drug conjugate (ADC) patritumab deruxtecan, the companies hoped to address manufacturing concerns flagged by the agency and quickly …

Source: Fierce Pharma - Neutral
Published on 13:53 GMT

MSD and Daiichi Sankyo pull HER3-DXd's FDA filing

A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by the FDA, and the partners have now withdrawn a filing intended to get the programme back on track. The decision to voluntarily …

Source: pharmaphorum - Neutral
Published on 09:49 GMT

Bristol Myers Squibb receives European approval for subcutaneous formulation of Opdivo across multiple solid tumour ...

Bristol Myers Squibb announced that the European Commission (EC) has approved a new Opdivo (nivolumab) formulation associated with a new route of administration (subcutaneous use [SC]), a new pharmaceutical form (solution for injection) and a new strength …

Source: Pharmabiz.com - Neutral
Published on 13:57 GMT

iTeos To Close Down After TIGIT Fail

iTeos Therapeutics’ strategic review from just days ago culminated in a decision to wind down the company’s operations and sell off its remaining assets and intellectual property, the biotech announced Wednesday. In an SEC filing on Tuesday, iTeos noted …

Source: BioSpace - Pending
Published on 14:09 GMT

Merck, Daiichi Pull US Application for 'guided Missile' Therapy for Lung Cancer

(Reuters) -Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it failed to prolong the lives of patients in a late-stage study, the companies said on Thursday. The treatment, …

Source: Medscape - Neutral
Published on 14:30 GMT

NHS to roll out ‘revolutionary’ blood test for lung cancer

People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid unnecessary biopsies, officials have announced. About 15,000 patients a year are expected to benefit from the world-first rollout, …

Source: Express & Star - Neutral
Published on 14:50 GMT

Merck, Daiichi pull approval application for ADC in lung cancer

Merck & Co. and Daiichi Sankyo have withdrawn an approval application in the U.S. for a lung cancer drug at the center of a multibillion-dollar alliance the companies formed two years ago. In a short statement Thursday, the companies said they’ve …

Source: BioPharma Dive - Pending

04 days 11:32:36

Featured Releases

Got News to Share? · Submit · See All

Published on May 29, 2025 - 13:05 GMT

Silexion Therapeutics Announces Groundbreaking Preclinical Results: SIL204 Shows Strong Efficacy in Pancreatic, ...

GRAND CAYMAN, Cayman Islands, May 29, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven …

Distribution channels:
Published on May 27, 2025 - 13:01 GMT

Lung Cancer Therapeutics Market Accelerates Amid Innovation, Policy Support, and R&D Deals | DataM Intelligence

Lung cancer therapeutics market booming with 10.5% CAGR through 2031, fueled by advances in immunotherapy, diagnostics, and global industry partnerships. AUSTIN, TX, UNITED STATES, May 27, 2025 /⁨EINPresswire.com⁩/ -- The global lung cancer …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 29, 2025 - 11:00 GMT

Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies

NEWTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced that the first patient has been …

Distribution channels: Technology ...
Published on May 28, 2025 - 16:33 GMT

Oxygen Conserving Devices Global Market Projected to Reach $3.41 Billion by 2029

The Business Research Company’s Oxygen Conserving Devices Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 28, 2025 - 12:23 GMT

Global CTLA4 Inhibitors Market Forecast: Key Growth Drivers, Trends, and Opportunities from 2025 to 2034

The Business Research Company's CTLA4 Inhibitors Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest …

Distribution channels: Business & Economy, Companies ...
Published on May 28, 2025 - 12:14 GMT

Key Trend Shaping The Radiation Oncology Market In 2025: Advanced Radiation Therapy Systems Enhancing Patient Outcomes

The Business Research Company’s Radiation Oncology Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /⁨EINPresswire.com⁩/ -- What Is The Forecasted Growth Of The Radiation …

Distribution channels: Business & Economy, Chemical Industry ...
Published on May 28, 2025 - 12:05 GMT

Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of ...

NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 28, 2025 - 12:30 GMT

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …

Distribution channels:

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 817,223,109 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 29, 2025 - 16:00 GMT

ICONIC NEW YORK BRANDS UNITE FOR YEAR TWO OF MEMORIAL SLOAN KETTERING CANCER CENTER’S NYC FOR MSK CAMPAIGN

Over 100 Participating Locations NEW YORK, NY, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- Memorial Sloan Kettering Cancer Center (MSK) announces the return of NYC for MSK to celebrate MSK’s 141st anniversary. For one day, New York City’s most …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on May 29, 2025 - 15:44 GMT

6 State and Local Tax Trends That Are Evolving From The Wayfair Decision of 7 Years Ago

Conflicting nexus definitions and sales tax exemptions can result in inappropriate payments, often creating overpayments. PHILADELPHIA, PA, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- In 2018, the United States Supreme Court decided the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on May 29, 2025 - 15:29 GMT

Itiliti Health Digitizes Over 650 Medical Policies Across Four Lines of Business at Major Blues Plan

EDEN PRAIRIE, MN, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- Itiliti Health, a leading innovator in prior authorization automation, is announcing the successful digitization of more than 650 medical policies, including carve-outs, across …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 15:25 GMT

Business Solutions Marketing Group Unlocks Key to Online Reputation: Announces ‘No Win, No Fee’ Review Removal Service

MECHANICSBURG, PA, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- Business Solutions Marketing Group, a leading digital marketing agency with over a decade of experience empowering small businesses, today unveiled a critical enhancement to its …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 15:22 GMT

Global Value-Based Healthcare Services Market Outlook 2025-2034: Growth Drivers, Share, And Trends

The Business Research Company’s Value-Based Healthcare Services Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- The Business Research …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 15:22 GMT

Primary Driver In Surgical Sealants & Tissue Patches Market 2025: Rise In Sports Injuries From High-Impact Activities

The Business Research Company's Surgical Sealants And Tissue Patches Global Market Report 2025 – Market Size, Trends, And Global Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- The surgical …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 15:22 GMT

Sarcomatrix Selected as Finalist for Prestigious Start-Up Stadium at BIO International Convention 2025

BOSTON, MA, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- Sarcomatrix Therapeutics Corp., a pioneering biotech company developing oral, mutation-agnostic therapies for muscle-wasting diseases, has been selected as a finalist for the highly …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 15:22 GMT

The Brookbush Institute Publishes NEW Article, Course, and Glossary Updates: 'Periodization Training: Who Needs It?'

The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- Excerpt from the article: Periodization …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 15:21 GMT

Rising Demand For Neurological Disorders: A Key Driver Transforming The Synthetic Cannabinoids Market 2025

The Business Research Company's Synthetic Cannabinoids Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global synthetic …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 15:21 GMT

Comprehensive Insights Of The Tendinopathy Market: Key Drivers, Trends, Growth Opportunities, And Forecast For 2025-2034

The Business Research Company's Tendinopathy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- The tendinopathy market will surge from $ …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 15:00 GMT

Trauma-Informed Parenting Workshop with Bryan Post Set for San Jose on June 12

SAN JOSE, CA, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- On June 12, 2025, national trauma expert Bryan Post will lead a live, in-person From Fear to Love workshop in San Jose, California, as part of his 2025 World Tour. Known for …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 29, 2025 - 15:00 GMT

Sacramento Plastic Surgeon Compares Facial Rejuvenation Procedures

Charles Perry, MD, FACS – a plastic surgeon in Sacramento – compares various facial rejuvenation procedures, including brow lift surgery and blepharoplasty. SACRAMENTO, CA, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- As a renowned plastic …

Distribution channels: Beauty & Hair Care, Companies ...
Published on May 29, 2025 - 15:00 GMT

Infocepts to Showcase Enterprise AI in Action at Databricks Data + AI Summit 2025

Join Infocepts at Booth F637 for live demos that bridge vision and execution with Databricks. SOUTH SAN FRANCISCO, CA, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- Infocepts, a global leader in AI-powered data solutions, is excited to …

Distribution channels: Banking, Finance & Investment Industry, Food & Beverage Industry ...
Published on May 29, 2025 - 14:43 GMT

Global Thermal Spa And Wellness Market: Key Trends, Market Share, Growth Drivers, And Forecast For 2025-2034

The Business Research Company's Thermal Spa And Wellness Global Market Report 2025 – Market Size, Trends, And Global Forecast 2024-2033 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- The thermal spa and wellness …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 14:15 GMT

DOCS Outside the Box Welcomes Pediatric Provider, Leslie Mallett, ARNP, to Innovative Holistic Medical Team

Leslie Mallett, ARNP, brings 12 years of pediatric care experience and a passion for blending holistic and traditional medicine to support family wellness. ST. PETERSBURG, FL, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- DOCS Outside the …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 14:00 GMT

Tickets Now On Sale for Vivacity – Canada’s First Consumer Show for Medical Aesthetics, Longevity, and Healthy Aging

VANCOUVER, BRITISH COLUMBIA, CANADA, May 29, 2025 /⁨EINPresswire.com⁩/ -- Tickets are now on sale for Vivacity, a first-of-its-kind Canadian event designed to empower individuals with clear, science-based information on medical aesthetics, …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on May 29, 2025 - 14:00 GMT

Health Professional Student Association Earns 2025 Candid Platinum Seal of Transparency

Candid Seals of Transparency are awarded based on the amount and quality of information a nonprofit shares with the public via its Candid profile. HUNTINGTON BEACH, CA, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The Health Professional …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 14:00 GMT

Smarteeva Announces API Integration Support for FDA's Electronic Submissions Gateway Next Generation

The company became an early adopter of a new cloud-based submission system launched in April 2025. SOUTHLAKE, TX, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- Smarteeva, a leading provider of AI-driven post-market surveillance solutions, …

Distribution channels: Business & Economy, Companies ...
Published on May 29, 2025 - 14:00 GMT

ReviveHealth™ Welcomes Gary Douville as COO to Lead Ops, Accelerate Tech and Advance Member Experience Amid Rapid Growth

A seasoned exec in digital health innovation and operational transformation, Douville brings proven leadership and a record of delivering impactful results. PONTE VEDRA, FL, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- ReviveHealth, Inc. ( …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on May 29, 2025 - 14:00 GMT

CD Bioglyco Unveils GlycoCLICK Solutions: A Powerful Platform for Streamlined Antibody Glycoengineering and Conjugation

NY, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- CD Bioglyco, a leading provider of glycobiology solutions, is pleased to introduce GlycoCLICK Solutions, a streamlined platform designed to empower scientists with precise, efficient, and …

Distribution channels: Chemical Industry, Companies ...